Bank of America’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$751K Sell
43,005
-30,884
-42% -$613K ﹤0.01% 4673
2025
Q4
$1.45M Sell
73,889
-39,250
-35% -$814K ﹤0.01% 4298
2025
Q3
$3.12M Buy
113,139
+40,274
+55% +$1.24M ﹤0.01% 4433
2025
Q2
$2.22M Buy
72,865
+18,244
+33% +$518K ﹤0.01% 4677
2025
Q1
$1.47M Buy
54,621
+35,233
+182% +$1.12M ﹤0.01% 4947
2024
Q4
$696K Buy
19,388
+5,188
+37% +$194K ﹤0.01% 5307
2024
Q3
$538K Sell
14,200
-1,252
-8% -$51.4K ﹤0.01% 5438
2024
Q2
$699K Buy
15,452
+4,122
+36% +$190K ﹤0.01% 5128
2024
Q1
$550K Sell
11,330
-2,792
-20% -$137K ﹤0.01% 5291
2023
Q4
$757K Sell
14,122
-19,703
-58% -$997K ﹤0.01% 5196
2023
Q3
$1.98M Buy
33,825
+15,626
+86% +$977K ﹤0.01% 4249
2023
Q2
$1.15M Sell
18,199
-5,026
-22% -$320K ﹤0.01% 4672
2023
Q1
$1.46M Buy
23,225
+3,192
+16% +$190K ﹤0.01% 4620
2022
Q4
$1.07M Buy
20,033
+10,162
+103% +$551K ﹤0.01% 4805
2022
Q3
$554K Sell
9,871
-4,072
-29% -$269K ﹤0.01% 5319
2022
Q2
$1.01M Sell
13,943
-8,687
-38% -$647K ﹤0.01% 4897
2022
Q1
$1.8M Sell
22,630
-1,510
-6% -$136K ﹤0.01% 4687
2021
Q4
$2.44M Buy
24,140
+4,184
+21% +$417K ﹤0.01% 4357
2021
Q3
$1.84M Buy
19,956
+3,130
+19% +$301K ﹤0.01% 4517
2021
Q2
$1.72M Sell
16,826
-9,299
-36% -$934K ﹤0.01% 4452
2021
Q1
$2.55M Buy
26,125
+10,711
+69% +$975K ﹤0.01% 4042
2020
Q4
$1.19M Buy
15,414
+870
+6% +$67.3K ﹤0.01% 4363
2020
Q3
$1.07M Sell
14,544
-5,723
-28% -$459K ﹤0.01% 4152
2020
Q2
$1.49M Buy
20,267
+8,186
+68% +$642K ﹤0.01% 3829
2020
Q1
$698K Buy
12,081
+1,404
+13% +$97.7K ﹤0.01% 4274
2019
Q4
$839K Sell
10,677
-14,627
-58% -$1.08M ﹤0.01% 4626
2019
Q3
$1.73M Sell
25,304
-5,801
-19% -$390K ﹤0.01% 4169
2019
Q2
$2.47M Sell
31,105
-34,589
-53% -$2.74M ﹤0.01% 3872
2019
Q1
$5.51M Buy
65,694
+31,137
+90% +$3.25M ﹤0.01% 3074
2018
Q4
$4.07M Buy
34,557
+20,835
+152% +$2.41M ﹤0.01% 3217
2018
Q3
$1.65M Sell
13,722
-8,104
-37% -$1.01M ﹤0.01% 4136
2018
Q2
$2.52M Buy
21,826
+2,540
+13% +$278K ﹤0.01% 3794
2018
Q1
$1.66M Sell
19,286
-9,817
-34% -$760K ﹤0.01% 4021
2017
Q4
$2.15M Buy
29,103
+28,010
+2,563% +$1.87M ﹤0.01% 3885
2017
Q3
$63K Buy
1,093
+243
+29% +$14.4K ﹤0.01% 5849
2017
Q2
$54K Sell
850
-6,714
-89% -$414K ﹤0.01% 5845
2017
Q1
$436K Sell
7,564
-905
-11% -$54K ﹤0.01% 4956
2016
Q4
$518K Sell
8,469
-1,473
-15% -$96K ﹤0.01% 4773
2016
Q3
$688K Sell
9,942
-30,734
-76% -$2.03M ﹤0.01% 4413
2016
Q2
$2.27M Buy
40,676
+39,886
+5,049% +$2.41M ﹤0.01% 3526
2016
Q1
$48K Sell
790
-4,564
-85% -$269K ﹤0.01% 5809
2015
Q4
$342K Buy
5,354
+4,996
+1,396% +$324K ﹤0.01% 5053
2015
Q3
$24K Sell
358
-2,436
-87% -$172K ﹤0.01% 6251
2015
Q2
$191K Buy
2,794
+878
+46% +$55.7K ﹤0.01% 5259
2015
Q1
$106K Buy
+1,916
New +$98.2K ﹤0.01% 5282
2014
Q4
Sell
-4,992
Closed -$184K 7982
2014
Q3
$184K Buy
4,992
+2,712
+119% +$97.9K ﹤0.01% 5458
2014
Q2
$89K Buy
2,280
+1,850
+430% +$68.7K ﹤0.01% 6224
2014
Q1
$16K Sell
430
-17,068
-98% -$596K ﹤0.01% 7012
2013
Q4
$661K Buy
17,498
+14,518
+487% +$556K ﹤0.01% 4505
2013
Q3
$129K Sell
2,980
-13,338
-82% -$535K ﹤0.01% 5790
2013
Q2
$591K Buy
+16,318
New +$496K ﹤0.01% 4592

Other funds holding USNA

Bank of America's USNA Position: Q1 2026 in Review

Bank of America reduced its Usana Health Sciences (USNA) stake by 42% in Q1 2026, selling an estimated $613K and leaving 43,005 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #4673.

Bank of America first reported a position in USNA in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.51M in Q1 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Bank of America held 43,005 shares of Usana Health Sciences worth $751K as of Q1 2026.
  • Bank of America sold 30,884 Usana Health Sciences shares in Q1 2026, an estimated $613K.
  • Usana Health Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4673 holding.
  • Bank of America first reported a position in Usana Health Sciences in Q2 2013 and has held it in 51 quarters since.
  • Bank of America's Usana Health Sciences position peaked at $5.51M in Q1 2019.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.